Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

U.S. Physical Therapy (USPH)

U.S. Physical Therapy (USPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

U.S. Physical Therapy 1300 WEST SAM HOUSTON PARKWAY SUITE 300 HOUSTON TX 77042 USA

www.usph.com Employees: 7,028 P: 713-297-7000

Sector:

Medical

Description:

U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.

Key Statistics

Overview:

Market Capitalization, $K 1,205,373
Enterprise Value, $K 1,575,573
Shares Outstanding, K 15,204
Annual Sales, $ 671,350 K
Annual Net Income, $ 31,420 K
Last Quarter Sales, $ 197,130 K
Last Quarter Net Income, $ 13,140 K
EBIT, $ 86,870 K
EBITDA, $ 105,970 K
60-Month Beta 1.32
% of Insider Shareholders 2.00%
Float, K 14,900
% Float 98.00%
Short Volume Ratio 0.58

Growth:

1-Year Return -15.93%
3-Year Return -6.30%
5-Year Return -34.03%
5-Year Revenue Growth 39.29%
5-Year Earnings Growth -21.63%
5-Year Dividend Growth 54.39%

Per-Share Information:

Most Recent Earnings 0.66 on 11/05/25
Next Earnings Date 02/25/26
Earnings Per Share ttm 2.60
EPS Growth vs. Prev Qtr -18.52%
EPS Growth vs. Prev Year -4.35%
Annual Dividend & Yield 1.80 (2.27%)
Annual Dividend & Yield (Fwd) 1.80 (2.36%)
Most Recent Dividend 0.450 on 11/17/25
Next Ex-Dividends Date 11/17/25
Dividend Payable Date 12/12/25
Dividend Payout Ratio 63.10%
Most Recent Split 3-2 on 06/29/01

USPH Ratios

Ratio
Price/Earnings ttm 29.33
Price/Earnings forward 28.91
Price/Earnings to Growth 3.53
Return-on-Equity % 8.62%
Return-on-Assets % 3.64%
Profit Margin % 4.68%
Debt/Equity 0.30
Price/Sales 1.73
Price/Cash Flow 21.98
Price/Book 2.30
Book Value/Share 33.21
Interest Coverage 8.51

USPH Dividends

Date Value
11/17/25 $0.4500
08/22/25 $0.4500
05/23/25 $0.4500
03/14/25 $0.4500
11/15/24 $0.4400
08/23/24 $0.4400
05/22/24 $0.4400
03/11/24 $0.4400
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar